Skip to main content

Pitfalls and Pearls in Gynecologic Pathology



Evaluated by: 
David B. Kaminsky, M.D., FIAC, November 9, 2018
Original release date: January 8, 2019
Access to this course expires on:  November 9, 2021, at 11:59 PM Pacific Time
CME 12.25

Course Description

The sub-specialized diversity of gynecologic pathology covers numerous sites, diseases and cancers with nuanced details regarding classification of disease, intra-operative consultations, newly-described tests, and staging of gynecologic malignancies. This course concentrates on the intricacies of these complex elements in an effort to enhance what is encountered in real-time clinical practice and introduces surgical pathologists to many of the “pitfalls and pearls” that can be encountered in the routine evaluation and reporting of gynecologic surgical pathology specimens. Whether you’re in clinical community or academic practice, or a pathologist-in-training, this information is invaluable to your performance.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Develop expertise in the interpretation of gynecologic frozen section and biopsy specimens 
  • Adequately use and interpret some of the most commonly used adjunctive studies in gynecologic pathology 
  • Evaluate staging pathologic parameters in gynecologic cancer consistently and precisely 
  • Develop comprehensive differential diagnoses in gynecologic pathology and use up-to-date knowledge and tools in resolving them 

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Beginning in 2021, the American Board of Pathology (ABPath) will no longer require Self-Assessment Modules (SAMs) for Part II Lifelong Learning of the Continuing Certification program. For additional information, visit the ABPath website.


Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships:  Charles Matthew Quick, M.D., Brooke E. Howitt, M.D., Vinita Parkash, M.D., Carlos Parra-Herran, M.D.

The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Charles Matthew Quick, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.


To earn CME credit, all learners must complete the evaluation. Your certificate will be available to view and print by clicking here.

Buy the entire Pitfalls and Pearls in Gynecologic Pathology course and get a great discount!

Not A Member? Click Here